eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
10/2003
vol. 7
 
Share:
Share:
more
 
 
abstract:

Evaluation of tolerance and efficacy of palliative irinotecan chemotherapy in patients with colorectal cancer

Beata Utracka-Hutka
,
Elżbieta Nowara
,
Grzegorz Słomian
,
Rafał Suwiński

Współcz Onkol (2003) vol. 7, 10 (767-771)
Online publish date: 2003/12/17
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
More than a half of colorectal cancer patients experience distant metastases, especially to the liver.
5-Fluorouracil based therapy modulated with folinic acid is the standard chemotherapy. Selected patients can be treated with second line chemotherapy based on the drugs with no cross-resistance with fluorouracil when they relapse. We present a group of 37 patients with metastatic colorectal cancer and analyze the efficacy of second line mono- or poli-chemotherapy based on irinotecan. Thirty four patients received irinotecan alone, and three combined with 5-fluorouracil. There were given 1 to 9 cycles, median 4.5. The response rate was 48.6% (18 pts) with partial remission 19% (7 pts). The median duration of response was 13.6 weeks (2-27 weeks). Four patients experienced progression after the first cycle. We did not observe any serious adverse events, discontinuation of treatment was not caused by SAE in any case. The most common adverse event was diarrhea – 10 pts (27%), but only one patient experienced grade 3 WHO, and fatigue – 5 pts (13.5%).
We conclude that second line chemotherapy can be useful in a selected group of patients with metastatic colorectal cancer.
keywords:

colorectal cancer, second line chemotherapy, irinotecan

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe